Best Practices for Analysis of In Vitro Transcribed mRNA

Facebook

Email

August 01, 2023

Best practices for Analysis of In Vitro Transcribed (IVT) mRNA

The recent rise of in vitro transcription (IVT) mRNA as a promising platform has emphasized the importance of dependable quality control analysis throughout the workflow. In the context of mRNA vaccine production, the IVT workflow offers various opportunities for quality control. This technical overview explores optimal handling practices for IVT mRNA and its analysis using Agilent’s Fragment Analyzer systems, including sample handling and quantification tips to ensure accurate and reliable results. Download this article to learn more about how Agilent’s Fragment Analyzer can be used in the IVT mRNA vaccine development workflow.

Oops! It looks like there were some errors.

Please check the highlighted fields and try again.

Download Now

login

Name *
Company/Institution *
Institution Type *
Address *
Email Address *
Work Phone Number *
Are you planning to purchase any lab products related to this content? *
I would like to be contacted by an Agilent representative by telephone or email *
Yes
No
I would like to receive updates and information about Agilent products, services, and events. For full details of how Agilent will treat your information please click here to view our privacy policy. *
Yes
No
Email & Subscription Preferences *
Topic - Specific eNewslettersNew Product Announcements and Special Offers from our trusted life science partners
Future Lab Topics
Trends in Live Cell ImagingTrends in Protein ProductionTrends in ImmunodetectionEstablishing and Maintaining a Cell Culture FacilityTrends in Flow CytometryAutomation in Drug DiscoveryTrends in Next Gen SequencingTrends in COVID-19 R&DTrends in Genomic ScreeningTrends in GenomicsAntibody-Based TherapeuticsOptimizing workflows

By submitting this form, you consent to Biocompare storing your email address and contact information and transmitting your contact information to the Future Lab sponsor. You also agree to receive email from Biocompare and the sponsor. You may request to be removed at any time.